Labs / Assays & in vitro testing
Allterum Therapeutics
Houston, TX, United States · allterum.com
GMP
Allterum Therapeutics develops precision oncology and inflammation therapies. Its lead program is 4A10, a monoclonal antibody targeting CD127, with work focused on relapsed leukemia, hematologic malignancies, and CD127-expressing solid tumors. The company is based in Houston and collaborates with cancer researchers and institutions in Texas and elsewhere in the U.S.
They take quote requests by email.
What they offer
Therapeutic antibody development
Develops monoclonal antibody therapeutics directed at specific disease targets, including CD127.
Precision oncology drug development
Advances oncology programs focused on targeted therapies for hematologic malignancies and solid tumors.
Inflammation therapeutics development
Develops therapies for inflammation-related indications as part of its precision medicine focus.
Translational science collaboration
Works with academic and clinical partners to advance therapeutic programs from discovery toward the clinic.
What they work on
- Modalities
- Small molecule, Antibody
- Therapeutic areas
- precision oncology, inflammation, relapsed leukemia, acute lymphoblastic leukemia (ALL), B-cell malignancies, lymphomas, solid tumors, hematologic malignancies
- Sites
- Houston, USA
- Address
- 10401 Town Park Drive, Houston TX 77072
- Founded
- 2013
Similar labs. Evotec, Hope Medicine (HopeMed), Biofidus GmbH, Esco Aster
Found in a contract services directory. Listing built from allterum.com. Work here? Claim this listing.